Published in Eur Respir Rev on December 01, 2009
Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat. Indian J Endocrinol Metab (2014) 0.92
Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany - results of the national telephone health interview survey 'German Health Update (GEDA)' 2009. BMC Public Health (2013) 0.88
Metabolic syndrome and chronic obstructive pulmonary disease. Lung India (2016) 0.86
Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects. Respir Res (2011) 0.85
Metabolic syndrome and carotid intima-media thickness in chronic obstructive pulmonary disease. Multidiscip Respir Med (2013) 0.79
The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.79
Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD? J Clin Med (2016) 0.75
Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05
Complete nucleotide sequence and identification of membrane components of the histidine transport operon of S. typhimurium. Nature (1982) 4.71
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J (2010) 2.77
Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology (1992) 2.65
Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47
Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J (2011) 2.38
Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36
Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36
Effect of sulindac on sporadic colonic polyps. Gastroenterology (1995) 2.27
Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J (2002) 2.26
Anti-Wra in newborn twins. Transfusion (1991) 2.02
Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 1.91
Sputum induction. Eur Respir J Suppl (2002) 1.88
Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J (2002) 1.79
Temporal change in deep-sea benthic ecosystems: a review of the evidence from recent time-series studies. Adv Mar Biol (2010) 1.76
De novo kidney graft tumors: results from a multicentric retrospective national study. Am J Transplant (2012) 1.74
Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells. Thorax (2009) 1.74
Rhinosinusitis in severe asthma. J Allergy Clin Immunol (2001) 1.72
Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J (2004) 1.70
Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med (1998) 1.69
Frequent exacerbators--a distinct phenotype of severe asthma. Clin Exp Allergy (2014) 1.69
Genetic diversity and subdivision of 57 European and Middle-Eastern sheep breeds. Anim Genet (2007) 1.68
Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol (1999) 1.68
Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med (2010) 1.65
Transforming growth factor-beta in human aqueous humor. Curr Eye Res (1990) 1.65
Iatrogenic eosinophilic pleural effusion. Eur Respir Rev (2011) 1.63
Survival in chronic hepatitis B. An analysis of 379 patients. Ann Intern Med (1984) 1.58
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy (2012) 1.55
Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J Allergy Clin Immunol (2001) 1.55
Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg (1998) 1.53
Metabolic syndrome and cerebral vasomotor reactivity. Eur J Neurol (2010) 1.53
Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol (1997) 1.53
Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J Virol (2001) 1.51
Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis. Eur Respir Rev (2010) 1.51
Critical role of cytosolic phospholipase A2{alpha} in bronchial mucus hypersecretion in CFTR-deficient mice. Eur Respir J (2010) 1.51
Update on severe asthma: what we know and what we need. Eur Respir Rev (2009) 1.50
The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis. Eur Respir J (2009) 1.49
Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD. Int J Chron Obstruct Pulmon Dis (2008) 1.46
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45
Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo. Eur Respir J (2011) 1.45
Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. Am J Respir Crit Care Med (2000) 1.44
Compliance in asthma. Respir Med (1999) 1.44
[Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis]. Rev Mal Respir (2010) 1.40
[COPD and inflammation: statement from a French expert group: inflammation and remodelling mechanisms]. Rev Mal Respir (2010) 1.40
[Inhalation devices: characteristics, modeling, regulation and use in routine practice. GAT Aerosolstorming, Paris 2011]. Rev Mal Respir (2012) 1.40
[Adult asthma exacerbations in questions]. Rev Mal Respir (2010) 1.40
[The clinical and economic assessment of surgery in the treatment of the obstructive sleep apnea syndrome. The Working Group assembled by the ANAES. L'Agence Nationale d'Accréditation et d'Evaluation en Santé. A synthesis]. Rev Stomatol Chir Maxillofac (1999) 1.39
Early activation defects in T lymphocytes from aged mice. Immunol Rev (1997) 1.38
[Analysis of induced sputum in the management of asthma: a valid technique, a service rendered by community pneumonologists]. Rev Mal Respir (2002) 1.38
[Thrombocytopenia induced by rifampicin not previously sensitized: a case presentation]. Rev Mal Respir (2013) 1.38
Using itraconazole to clear Batrachochytrium dendrobatidis infection, and subsequent depigmentation of Alytes muletensis tadpoles. Dis Aquat Organ (2009) 1.38
Liver transplantation: therapeutic option in end-stage liver disease. Tex Med (1988) 1.37
Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis (1992) 1.31
Jejunostomy: techniques, indications, and complications. World J Surg (1999) 1.31
Asthma: a disease remodeling the airways. Allergy (1992) 1.30
Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med (1996) 1.28
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest (1996) 1.28
Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J (2003) 1.27
Neutrophils in chronic inflammatory airway diseases: can we target them and how? Eur Respir J (2010) 1.27
In vivo interactions of genes and proteins in DNA replication and recombination of phage T4. Cold Spring Harb Symp Quant Biol (1979) 1.26
HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis (1993) 1.26
Chest radiography and high resolution computed tomography of the lungs in asthma. Am Rev Respir Dis (1992) 1.26
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Are overweight asthmatics more difficult to control? Allergy (2006) 1.22
A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype. Am J Gastroenterol (2000) 1.21
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Inhaler devices for asthma: a call for action in a neglected field. Eur Respir J (2011) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus. Proc Natl Acad Sci U S A (1986) 1.17
Functional characteristics of bronchial epithelium obtained by brushing from asthmatic and normal subjects. Am Rev Respir Dis (1993) 1.17
Food-frequency questionnaire validation among Mexican-Americans: Starr County, Texas. Ann Epidemiol (1995) 1.17
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol (1991) 1.17
Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine (2001) 1.16
Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction. Hepatology (1991) 1.15
Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia? Neurology (2005) 1.15
Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol (1987) 1.14
Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.12
Pathobiology of pulmonary hypertension. The role of platelets and thrombosis. Clin Chest Med (2001) 1.11
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial. Eur Respir J (2010) 1.08
Update on the roles of distal airways in COPD. Eur Respir Rev (2011) 1.07
Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? Eur Respir J (2004) 1.07
Gender and adjustment to chronic disease. A study of couples with colon cancer. Gen Hosp Psychiatry (1989) 1.06
Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med (1996) 1.05
Long-term oral corticosteroid therapy does not alter the results of immediate-type allergy skin prick tests. J Allergy Clin Immunol (1996) 1.05
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology (2004) 1.04